Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Regular, moderate exercise reduces the risk of colds in postmenopausal women

Regular, moderate exercise reduces the risk of colds in postmenopausal women

October 26, 2006

SEATTLE - Postmenopausal women who want to decrease their risk of colds would be well advised to dust off their sneakers and get moving, suggests a new study led by researchers at Fred Hutchinson Cancer Research Center.

Through the first randomized clinical trial to investigate the impact of moderate physical activity on common-cold incidence, Cornelia (Neli) Ulrich, Ph.D., and colleagues found that postmenopausal women who exercised regularly for a year had about half the risk of colds compared to those who did not work out routinely. The findings appear in the November issue of The American Journal of Medicine.




"This adds another good reason to put exercise on your to-do list, especially now that cold season is here," said Ulrich, the paper's senior author and an associate member of the Hutchinson Center's Public Health Sciences Division. However, Ulrich is quick to point out that regular exercise in moderation - such as 30 to 45 minutes of brisk walking each day - is the key; other studies have shown that excessive, exhaustive exercise can deplete immune function and increase the risk of colds.

The researchers found that the ability of moderate exercise to ward off colds seemed to increase over time. "The enhanced immunity was strongest in the final quarter of the year-long exercise intervention," Ulrich said. "This suggests that when it comes to preventing colds, it's really important to stick with exercise long term." Overall, the non-exercisers experienced about twice as many colds as the exercisers, but in the last three months of the intervention, the non-exercisers had a threefold greater chance of coming down with colds.

The yearlong study involved 115 previously sedentary, overweight, postmenopausal Seattle-area women. None smoked or took hormone-replacement therapy. Half were randomly assigned to a moderate-intensity, aerobic-exercise group and half, who served as a comparison group, attended a weekly stretching class.

While the members of the exercise group were asked to work out at home and at a gym for 45 minutes a day, five days a week, in fact they achieved an average of about 30 minutes of exercise per day. "They were supposed to do a little more exercise, but even so, we found it was enough activity to boost immune function in the long run," Ulrich said.

Brisk walking was the activity of choice, accounting for 52 percent of gym-based and 74 percent of home-based exercise. "It's been shown that just a 30-minute walk can increase levels of leukocytes, which are part of the family of immune cells that fight infection," Ulrich said, referring to a possible biological explanation for the protective effect.

A major strength of this study was its yearlong duration, large number of participants and randomized, controlled, clinical-trial design, considered the gold standard of study designs in medicine.

Even though the study was larger and longer than others that have addressed the impact of exercise on the risk of colds and upper-respiratory infections, it still may not have had enough participants or followed them long enough to provide a definitive answer, cautioned first author Jessica Chubak, a research associate at the Hutchinson Center. "It would be interesting to see what would happen over the course of a longer exercise intervention," she said.

The overall goal of the study, funded by the National Cancer Institute, was to assess the impact of physical activity on markers of breast-cancer risk. In addition to reducing their incidence of colds, the women in the exercise group also achieved significant reductions in weight, total-body fat and intra-abdominal fat.

In addition to Ulrich, Chubak and colleagues at the Hutchinson Center, collaborators on the study also included investigators from the University of Washington, University of Alberta and University of New Mexico.

According to the National Institute of Allergy and Infectious Diseases, Americans suffer an estimated 1 billion colds per year, resulting in a leading cause of doctor visits and missed days from work and school. Adults in the United States report an average of two to four colds per year.

Fred Hutchinson Cancer Research Center



Related Postmenopausal Current Events and Postmenopausal News Articles Postmenopausal Current Events and Postmenopausal News RSS Postmenopausal Current Events and Postmenopausal News RSS
Menopause-cardiology consensus statement on cardiovascular disease and on HRT
A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT.

Mayo researchers find robotic repair for vaginal prolapse has significant benefits
New Mayo Clinic research has found that robotic surgery for vaginal prolapse dramatically reduces patient hospital stay and recovery time.

Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.

Postmenopausal women with higher testosterone levels
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels.

Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women.

Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent
SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

Researchers believe hormone therapy should not be stopped prior to mammograms
Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings.

Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance
The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop.

Postmenopausal women benefit from endurance training as much as younger women
Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples.

Seizure drug enhances sleep for women with hot flashes
Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health.
More Postmenopausal Current Events and Postmenopausal News Articles
Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 3rd Edition

Treatment of the Postmenopausal Woman: Basic and Clinical Aspects, 3rd Edition
by Rogerio A. Lobo (Editor)

For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic work combines the best from two well-known references: Menopause, and the second edition of Treatment of the Postmenopausal Woman. By adding significant discussions of the basic science behind menopause, it is possible to objectively assess the clinical value and limitations of current approaches to treatment and provide a basis and rationale for strategies that will result in better individualized and specialized care. Not only does the third edition discuss diagnosis and treatment of menopause but it covers biological, anatomical, physiological, pathobiological, and pharmacological aspects as well bringing together, in one source, all of the information needed to understand and treat postmenopausal...

Femgest Progesterone 2/2 fl oz Cream

Femgest Progesterone 2/2 fl oz Cream
by Home Health

An organically based form of progesterone cream designed for women of all ages, FemGest provides a gentle, holistic approach to your body's need for balance. Featuring progesterone combined with soothing aloe vera and grapefruit extract, FemGest is ideal for those times when you want a supportive, soothing cream that harmonizes with your unique nature.

  Peri- and Postmenopausal Mood and Associated Symptoms



Healthy Aging Nutraceuticals Osteo Support 120 Tab

Healthy Aging Nutraceuticals Osteo Support 120 Tab
by Healthy Aging Nutraceuticals

Healthy bones need more than just calcium, and this is the best product we have found. A combination mineral, nutrient and herbal formulation, Osteo Support contains all the supplements you need to build and protect bones. We use it most often for bone injuries and for pre- and postmenopausal women who want a good quality calcium supplement.

  Hormone therapy debate continues post WHI: the effects of postmenopausal HT on both heart disease risk and breast cancer risk remain unclear.(Women's Health): An article from: Internal Medicine News
by Bruce K. Dixon (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on November 1, 2006. The length of the article is 1698 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Hormone therapy debate continues post WHI: the effects of postmenopausal HT on both heart disease risk and breast cancer risk remain unclear.(Women's Health)
Author: Bruce K. Dixon
Publication: Internal Medicine News (Magazine/Journal)
Date: November 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 21 Page: 24(1)

Distributed by Thomson...

  Close follow-up OK for many small ovarian cysts. (Asymptomatic Postmenopausal Women).: An article from: Family Practice News
by Sherry Boschert (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2003. The length of the article is 611 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Close follow-up OK for many small ovarian cysts. (Asymptomatic Postmenopausal Women).
Author: Sherry Boschert
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 3 Page: 41(1)

Distributed by Thomson...

Postmenopausal Hormone Therapy: Weighing the Benefits and Risks (NCME Video 695)

Postmenopausal Hormone Therapy: Weighing the Benefits and Risks (NCME Video 695)
Also With: Leon Speroff (Primary Contributor), Network For Continuing Medical Education (Primary Contributor)



  Primary Hyperparathyroidism of Post-Menopausal Women: Prospective Population-Based Case-Control Analysis on Prevalence, Clinical Findings and Treatment ... Summaries of Uppsala Dissertations, 820)
by Ewa Lundgren (Author)



  Raloxifene linked to reduced risk of stroke, TIA. (In High-Risk, Postmenopausal Women).(transient ischemic attack): An article from: Internal Medicine News
by Mitchel L. Zoler (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2003. The length of the article is 996 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Raloxifene linked to reduced risk of stroke, TIA. (In High-Risk, Postmenopausal Women).(transient ischemic attack)
Author: Mitchel L. Zoler
Publication: Internal Medicine News (Magazine/Journal)
Date: January 15, 2003
Publisher: International Medical News Group
Volume: 36 Issue: 2 Page: 45(1)

Distributed by Thomson...

  HT may benefit postmenopausal cognition, memory: three new studies contradict past results.(News)(Hormone therapy): An article from: Internal Medicine News
by Michele G. Sullivan (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on September 1, 2008. The length of the article is 1199 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: HT may benefit postmenopausal cognition, memory: three new studies contradict past results.(News)(Hormone therapy)
Author: Michele G. Sullivan
Publication: Internal Medicine News (Magazine/Journal)
Date: September 1, 2008
Publisher: International Medical News Group
Volume: 41 Issue: 17 Page: 1(3)

Distributed by Gale, a part of Cengage...

© 2009 BrightSurf.com